[go: up one dir, main page]

ATE110262T1 - Vorrichtung für kontrollierte wirkstoffabgabe mit einem undurchlässigen ueberzug und austrittsöffnung für die wirkstoffabgabe. - Google Patents

Vorrichtung für kontrollierte wirkstoffabgabe mit einem undurchlässigen ueberzug und austrittsöffnung für die wirkstoffabgabe.

Info

Publication number
ATE110262T1
ATE110262T1 AT89308645T AT89308645T ATE110262T1 AT E110262 T1 ATE110262 T1 AT E110262T1 AT 89308645 T AT89308645 T AT 89308645T AT 89308645 T AT89308645 T AT 89308645T AT E110262 T1 ATE110262 T1 AT E110262T1
Authority
AT
Austria
Prior art keywords
agents
delivery
impreachable
port
cover
Prior art date
Application number
AT89308645T
Other languages
English (en)
Inventor
John Nicholas Staniforth
Original Assignee
Co Ordinated Drug Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Co Ordinated Drug Dev filed Critical Co Ordinated Drug Dev
Application granted granted Critical
Publication of ATE110262T1 publication Critical patent/ATE110262T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Coating Apparatus (AREA)
  • Paints Or Removers (AREA)
AT89308645T 1988-08-26 1989-08-25 Vorrichtung für kontrollierte wirkstoffabgabe mit einem undurchlässigen ueberzug und austrittsöffnung für die wirkstoffabgabe. ATE110262T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888820353A GB8820353D0 (en) 1988-08-26 1988-08-26 Controlled release tablet

Publications (1)

Publication Number Publication Date
ATE110262T1 true ATE110262T1 (de) 1994-09-15

Family

ID=10642806

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89308645T ATE110262T1 (de) 1988-08-26 1989-08-25 Vorrichtung für kontrollierte wirkstoffabgabe mit einem undurchlässigen ueberzug und austrittsöffnung für die wirkstoffabgabe.

Country Status (10)

Country Link
US (1) US5004614A (de)
EP (1) EP0365123B1 (de)
AT (1) ATE110262T1 (de)
AU (1) AU4218489A (de)
CA (1) CA1339079C (de)
DE (1) DE68917677T2 (de)
ES (1) ES2058543T3 (de)
GB (2) GB8820353D0 (de)
IE (1) IE63764B1 (de)
WO (1) WO1990001925A1 (de)

Families Citing this family (112)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366738A (en) * 1982-07-29 1994-11-22 Merck & Co., Inc. Controlled release drug dispersion delivery device
US5178866A (en) * 1990-03-23 1993-01-12 Alza Corporation Dosage form for delivering drug to the intestine
HUT69680A (en) * 1990-08-09 1995-09-28 Endocon Inc Implant and apparatus for delivering multiple drug and process for production of theese
US5266325A (en) * 1990-09-28 1993-11-30 Hydro Med Science Division Of National Patent Development Corp. Preparation of homogeneous hydrogel copolymers
AU651654B2 (en) * 1992-01-14 1994-07-28 Endo Pharmaceuticals Solutions Inc. Manufacture of water-swellable hydrophilic articles and drug delivery devices
AU655596B2 (en) * 1990-10-01 1995-01-05 Pharmacia & Upjohn Company Lateral edge coated controlled release pharmaceutical compositions
US5922342A (en) * 1990-10-01 1999-07-13 Pharmacia & Upjohn Company Lateral edge coated controlled release pharmaceutical compositions
WO1992011845A1 (en) * 1991-01-03 1992-07-23 Glaxo Canada Inc. Method for production of solid pharmaceutical preparation
US5543154A (en) * 1991-12-27 1996-08-06 Merck & Co., Inc. Controlled release nifedipine delivery device
AU3917393A (en) * 1992-05-12 1993-12-13 Church & Dwight Company, Inc. Fungicide compositions
AU3801893A (en) * 1992-05-12 1993-12-13 Church & Dwight Company, Inc. Insecticide compositions
WO1993022919A1 (en) * 1992-05-12 1993-11-25 Church & Dwight Company, Inc. Herbicide compositions
DK0636551T3 (da) * 1993-07-12 1996-08-26 Nestle Sa Beholderlukke med sikkerhedsring
DE4431653C2 (de) 1994-09-06 2000-01-20 Lohmann Therapie Syst Lts Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung
US6342570B1 (en) * 1994-11-14 2002-01-29 Novartis Ag Cross-linkable copolymers and hydrogels
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device
US5830884A (en) * 1995-01-18 1998-11-03 National Starch And Chemical Investment Holding Corporation Pharmaceutical products containing thermally-inhibited starches
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US20060280774A1 (en) * 1995-06-02 2006-12-14 Allergan, Inc. Compositions and methods for treating glaucoma
US5733270A (en) * 1995-06-07 1998-03-31 Baxter International Inc. Method and device for precise release of an antimicrobial agent
DK1308159T3 (da) * 1995-09-21 2005-02-14 Pharma Pass Ii Llc Farmaceutisk sammensætning indeholdende en syre-labil omeprazol og fremgangsmåde til fremstilling deraf
US6361796B1 (en) * 1996-10-25 2002-03-26 Shire Laboratories, Inc. Soluble form osmotic dose delivery system
DE19728249C2 (de) * 1997-07-02 2001-05-03 Georgios Pandalis Produkt aus einem Kern und mindestens einer ein Naturharz enthaltenden Umhüllung, Steckkapsel, Verfahren zur Herstellung einer Filmtablette, Weichkapsel, Steckkapsel und Verwendung von Naturharzen
US6110500A (en) * 1998-03-25 2000-08-29 Temple University Coated tablet with long term parabolic and zero-order release kinetics
US20040102486A1 (en) * 1998-11-12 2004-05-27 Smithkline Beecham Corporation Novel method of treatment
US20040081697A1 (en) * 1998-11-12 2004-04-29 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
US20030153607A1 (en) * 1998-11-12 2003-08-14 Smithkline Beecham P.L.C. Novel composition and use
US6331313B1 (en) 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
US6497157B1 (en) * 1999-11-29 2002-12-24 Distek, Inc. Intrinsic dissolution apparatus with stationary sample holder
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
US6569152B2 (en) 2000-03-21 2003-05-27 Farrington Pharmaceuticals, Llc Sustained release delivery systems for solutes
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
GB0027471D0 (en) * 2000-11-08 2000-12-27 Smithkline Beecham Plc Processes
ES2250504T3 (es) * 2000-11-29 2006-04-16 Allergan Inc. Prevencion del rechazo de injerto en el ojo.
US6544557B2 (en) * 2001-01-09 2003-04-08 Pan Pharmaceutical Limited Effervescent tablet compositions
CN1551770A (zh) * 2001-07-06 2004-12-01 ������ҩ�����޹�˾ 羟吗啡酮控释制剂
ES2501142T3 (es) * 2001-07-12 2014-10-01 Given Imaging Ltd. Dispositivo para examinar una cavidad interna corporal
GB0117618D0 (en) * 2001-07-19 2001-09-12 Phoqus Ltd Pharmaceutical dosage form
GB0120835D0 (en) * 2001-08-28 2001-10-17 Smithkline Beecham Plc Process
US7850758B2 (en) * 2006-01-17 2010-12-14 The Andersons, Inc. Safened insecticide matter
US20040253312A1 (en) * 2001-09-28 2004-12-16 Sowden Harry S. Immediate release dosage form comprising shell having openings therein
NZ532097A (en) * 2001-09-28 2006-02-24 Mcneil Ppc Inc Dosage forms having an inner core and outer shell
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
PE20030800A1 (es) * 2002-02-12 2003-10-31 Glaxo Group Ltd Forma de dosificacion oral de liberacion controlada
GB0203296D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
JP2005522241A (ja) * 2002-03-11 2005-07-28 アルコン，インコーポレイテッド 移植可能な薬物送達システム
US8637512B2 (en) * 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
KR100882707B1 (ko) * 2002-07-29 2009-02-06 글락소 그룹 리미티드 라모트리진을 포함하는 서방형 제제
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
US7037521B2 (en) * 2003-03-28 2006-05-02 Bausch & Lomb Incorporated Using a laser for cutting a hole in a capsule for controlled drug delivery
EP1615626B1 (de) * 2003-04-24 2009-10-14 Jagotec Ag Tablette mit gefärbtem kern
WO2004112756A1 (en) 2003-06-26 2004-12-29 Isa Odidi Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
PE20050335A1 (es) * 2003-08-07 2005-06-01 Sb Pharmco Inc Forma de dosificacion oral que comprende 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona y procedimiento para la preparacion
GB0318824D0 (en) * 2003-08-11 2003-09-10 Glaxo Group Ltd Novel composition
JP2007512350A (ja) * 2003-11-25 2007-05-17 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロール組成物の治療および送達方法
WO2005051322A2 (en) * 2003-11-25 2005-06-09 Sb Pharmco Puerto Rico Inc. Controlled release pharmaceutical formulations comprising carvedilol, free based and its salts
US8067029B2 (en) 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US7879354B2 (en) 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
WO2005074976A1 (en) * 2004-02-09 2005-08-18 Transfert Plus Société En Commandite Composition comprising polymeric material and uses thereof
US20050244469A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
US8062652B2 (en) 2004-06-17 2011-11-22 Endo Pharmaceuticals Solutions Inc. Compositions and methods for treating precocious puberty
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
CA2491665A1 (fr) * 2004-12-24 2006-06-24 Louis Cartilier Formulation de comprime pour liberation soutenue de principe actif
EP1853221A2 (de) * 2005-02-03 2007-11-14 Duramed Pharmaceuticals, Inc. Vorrichtungen zur abgabe von mitteln in einen vaginaltrakt
US7905181B2 (en) * 2005-02-05 2011-03-15 Ciesiun Paul M Bioluminescent paintball
WO2006099288A2 (en) * 2005-03-11 2006-09-21 Indevus Pharmaceuticals, Inc. Controlled release formulations of octreotide
US7759312B2 (en) * 2005-03-11 2010-07-20 Endo Pharmaceuticals Solutions Inc. Delivery of dry formulations of octreotide
US20060228487A1 (en) * 2005-04-11 2006-10-12 J. Rettenmaier & Söehne GmbH + Co. KG Methods of combining active agents with augmented microcrystalline cellulose
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US20070009573A1 (en) * 2005-07-07 2007-01-11 L N K International Method of forming immediate release dosage form
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US20070178138A1 (en) * 2006-02-01 2007-08-02 Allergan, Inc. Biodegradable non-opthalmic implants and related methods
US20090304768A1 (en) * 2006-02-15 2009-12-10 Intec Pharma Ltd Gastro-Retentive System for the Delivery of Macromolecules
CN101453993A (zh) * 2006-04-03 2009-06-10 伊萨·奥迪迪 含有机溶胶涂层的受控释放递送物件
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
US20070298073A1 (en) * 2006-06-23 2007-12-27 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US8802128B2 (en) * 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
SG10201503411QA (en) 2006-08-03 2015-06-29 Nitec Pharma Ag Delayed-release glucocorticoid treatment of rheumatoid disease
EP1916006A1 (de) * 2006-10-19 2008-04-30 Albert Schömig Wachs oder Harz beschichtetes Implantat
EP1913960A1 (de) * 2006-10-19 2008-04-23 Albert Schömig Beschichtetes Implantat
NZ580803A (en) * 2007-04-27 2012-03-30 Endo Pharmaceuticals Solutions Implant device release agents and methods of using same
AU2008302460A1 (en) * 2007-09-17 2009-03-26 Mcneil-Ppc, Inc. Dip coated compositions containing copolymer of polyvinyl alcohol and polyethylene glycol and a gum
US20090196924A1 (en) * 2008-02-04 2009-08-06 Pramod Kharwade Controlled-release lamotrigine formulations
US20090312627A1 (en) * 2008-06-16 2009-12-17 Matott Laura A Radio-labeled ingestible capsule
US8071537B2 (en) * 2008-06-25 2011-12-06 Endo Pharmaceuticals Solutions Inc. Implantable device for the sustained release of a polypeptide
KR20110025974A (ko) 2008-06-25 2011-03-14 엔도 파마슈티컬즈, 솔루션스 아이엔씨. 이형제를 함유하는 옥트레오티드 이식물
US20100323016A1 (en) * 2008-07-18 2010-12-23 Biljana Nadjsombati Modified release formulation and methods of use
EP2318001A4 (de) * 2008-07-18 2013-02-20 Valeant Pharmaceuticals Int Formulierung mit modifzierter freisetzung und verwendungsverfahren
US20100323015A1 (en) * 2008-07-18 2010-12-23 Biljana Nadjsombati Modified release formulation and methods of use
CA2749646A1 (en) * 2009-01-26 2010-07-29 Nitec Pharma Ag Delayed-release glucocorticoid treatment of asthma
EP4578502A3 (de) 2009-02-26 2025-10-08 Glaxo Group Limited Pharmazeutische formulierungen enthaltend 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
US20100297195A1 (en) 2009-05-20 2010-11-25 Ranbaxy Laboratories Limited Controlled release lamotrigine formulations
US20110052686A1 (en) * 2009-09-03 2011-03-03 Ranbaxy Laboratories Limited Modified release lamotrigine tablets
US8187617B2 (en) * 2009-09-11 2012-05-29 William Wayne Howard Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
EP2515759A4 (de) 2009-12-23 2015-01-21 Given Imaging Inc Verfahren zur bewertung einer verstopfung mithilfe einer einnehmbaren kapsel
EA201290659A1 (ru) 2010-01-20 2013-05-30 Глэксо Груп Лимитед Новая композиция ретигабина
USPP22279P2 (en) 2010-09-02 2011-11-29 Floranova Service Corp Ipomoea plant named ‘IPOSGLGRE’
US9233076B2 (en) 2010-12-13 2016-01-12 Purdue Pharma L.P. Controlled release dosage forms
US9351924B2 (en) * 2011-03-11 2016-05-31 Snu R&Db Foundation Drug delivery system including laminated structure
PH12014500518A1 (en) * 2011-09-09 2019-10-11 Axxia Pharmaceuticals Llc Silicone coated implants
AU2017238123A1 (en) * 2016-03-23 2018-09-27 E. I. Du Pont De Nemours And Company Agricultural systems, compositions and methods for increasing crop yield
US10988442B2 (en) * 2016-11-09 2021-04-27 Novomedix, Llc Nitrite salts of 1,1-dimethylbiguanide, pharmaceutical compositions, and methods of use
WO2019067452A1 (en) 2017-09-27 2019-04-04 Pioneer Hi-Bred International, Inc. GROUND APPLICATION OF CROP PROTECTION AGENTS
CN112955249A (zh) 2018-11-01 2021-06-11 纳幕尔杜邦公司 用于制造农业芯的受控释放的系统和方法
CN113840595A (zh) 2019-05-17 2021-12-24 葛兰素史密斯克莱知识产权发展有限公司 基质组合物，其包含(S)-5-苄基-N-(5-甲基-4-氧代-2,3,4,5-四氢苯并[b][1,4]氧氮杂环庚三烯-3-基)-4H-1,2,4-三唑-3-甲酰胺
US20220175719A1 (en) * 2020-10-24 2022-06-09 Mason Cave Dissolvable thc beverage tablet production method
CN115737580B (zh) * 2022-12-06 2024-04-30 海南皇隆制药股份有限公司 一种提高降血糖效率的伏格列波糖片及其制备方法

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB972128A (en) * 1960-01-21 1964-10-07 Wellcome Found Pellets for supplying biologically active substances to ruminants and the manufacture of such pellets
GB1022171A (en) * 1961-06-15 1966-03-09 Wellcome Found Prolonged release oral pharmaceutical tablets and their manufacture
FR7805M (de) * 1964-04-09 1970-05-20
NL175029C (nl) * 1970-12-23 1984-09-17 Boehringer Sohn Ingelheim Depotdragee, die bekleed is met een onoplosbare en onverteerbare schaal, die op een of meer plaatsen een uitsparing vertoont.
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
CA1024891A (en) * 1972-06-06 1978-01-24 Boehringer Ingelheim G.M.B.H. Coated retard tablets with exponential release of active ingredient
US4036227A (en) * 1973-04-25 1977-07-19 Alza Corporation Osmotic releasing device having a plurality of release rate patterns
US3924622A (en) * 1973-10-11 1975-12-09 Mead Johnson & Co Zero-order release method
DE2438965A1 (de) * 1974-08-14 1976-02-26 Hoechst Ag Basisch substituierte 3,4-dihydro2h-isochinolin-1-thione und verfahren zu ihrer herstellung
US4093708A (en) * 1974-12-23 1978-06-06 Alza Corporation Osmotic releasing device having a plurality of release rate patterns
US3952741A (en) * 1975-01-09 1976-04-27 Bend Research Inc. Controlled release delivery system by an osmotic bursting mechanism
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4058122A (en) * 1976-02-02 1977-11-15 Alza Corporation Osmotic system with laminated wall formed of different materials
US4014334A (en) * 1976-02-02 1977-03-29 Alza Corporation Laminated osmotic system for dispensing beneficial agent
US4111203A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system with means for improving delivery kinetics of system
US4218433A (en) * 1977-03-03 1980-08-19 Nippon Kayaku Kabushiki Kaisha Constant-rate eluting tablet and method of producing same
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4271113A (en) * 1978-04-17 1981-06-02 Alza Corporation Process for forming a passageway in an osmotic device
US4217898A (en) * 1978-10-23 1980-08-19 Alza Corporation System with microporous reservoir having surface for diffusional delivery of agent
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
DE2922522A1 (de) * 1979-06-01 1980-12-04 Dudzik Joachim Tablette
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4519801A (en) * 1982-07-12 1985-05-28 Alza Corporation Osmotic device with wall comprising cellulose ether and permeability enhancer
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
GB8322007D0 (en) * 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
US4610686A (en) * 1983-11-02 1986-09-09 Alza Corporation Controlled delivery of haloperidol by an osmotic delivery system
GB8403138D0 (en) * 1984-02-07 1984-03-14 Graham N B Sustained release of active ingredient
US4601893A (en) * 1984-02-08 1986-07-22 Pfizer Inc. Laminate device for controlled and prolonged release of substances to an ambient environment and method of use
US4772474A (en) * 1985-08-09 1988-09-20 Alza Corporation Dispenser with internal arrangement of lamina means for dispensing beneficial agent
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
US4609374A (en) * 1985-04-22 1986-09-02 Alza Corporation Osmotic device comprising means for governing initial time of agent release therefrom
US4693886A (en) * 1985-04-22 1987-09-15 Alza Corporation Osmotic device with inert core
US4663147A (en) * 1985-09-03 1987-05-05 International Minerals & Chemical Corp. Disc-like sustained release formulation
IT1188212B (it) * 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
US4857330A (en) * 1986-04-17 1989-08-15 Alza Corporation Chlorpheniramine therapy
FR2599624B2 (fr) * 1986-06-09 1990-06-29 Virbac Dispositif a liberation programmee
US4816262A (en) * 1986-08-28 1989-03-28 Universite De Montreal Controlled release tablet
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
US4830860A (en) * 1986-10-30 1989-05-16 Pfizer Inc. Stressed polymeric device for controlled release of a substance to an ambient environment
US4792448A (en) * 1987-06-11 1988-12-20 Pfizer Inc. Generic zero order controlled drug delivery system
US4814183A (en) * 1987-08-31 1989-03-21 Merck & Co., Inc. Device for the controlled release of drugs with Donnan-like modulation by charged insoluble resins

Also Published As

Publication number Publication date
CA1339079C (en) 1997-07-29
AU4218489A (en) 1990-03-23
US5004614A (en) 1991-04-02
GB8919448D0 (en) 1989-10-11
WO1990001925A1 (en) 1990-03-08
EP0365123A1 (de) 1990-04-25
GB2222948B (en) 1993-02-03
GB2222948A (en) 1990-03-28
EP0365123B1 (de) 1994-08-24
DE68917677D1 (de) 1994-09-29
GB8820353D0 (en) 1988-09-28
DE68917677T2 (de) 1994-12-22
ES2058543T3 (es) 1994-11-01
IE892736L (en) 1990-02-26
IE63764B1 (en) 1995-06-14

Similar Documents

Publication Publication Date Title
ATE110262T1 (de) Vorrichtung für kontrollierte wirkstoffabgabe mit einem undurchlässigen ueberzug und austrittsöffnung für die wirkstoffabgabe.
ES8800836A1 (es) Metodo de fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos.
EP0577646A4 (en) Sustained release drug delivery devices
EP0479564A3 (en) Fluid metering and coating device
ES2132693T3 (es) Sistema osmotico para el suministro a animales bovinos de somatotropina sensible a los fluidos.
ATA88084A (de) Vorrichtung zur kontrollierten abgabe eines wirkstoffes
PT72904A (en) Device for the metered release of active ingredient
BR8103649A (pt) Dispositivo e processo para a liberacao controlade de um material ativo em um meio liquido processo para fazer um corpo soluvel ser humano ou animal
DE69531773D1 (de) Vorrichtung zur verabreichung von nützlichen stoffen an wiederkäuer
DE69116294D1 (de) System und Einrichtung für die verbesserte Atomisierung eingespritzten Kraftstoffes
BE892525A (fr) Appareil d'atomisation et de distribution de matieres de revetement
IL88123A0 (en) Device for the pulsed delivery of an irrigation liquid,and irrigation facilities incorporating the same device
FR2582797B1 (fr) Dispositif de freinage et de liberation pour un corps de tuyere rotative pour le guidage d'un engin volant
JPS5542894A (en) Nozzle valve for coating device in metal mold
FR1248714A (fr) Procédé et dispositif pour déterminer les conditions de l'irrigation sanguine d'un corps vivant
FR2347166A1 (fr) Dispositif perfectionne pour la preparation et la distribution de gachees destinees a l'enduisage ou a des fins similaires
FR2518496B1 (fr) Dispositif pour l'alimentation en etiquettes et vignettes analogues
NL7806566A (nl) Werkwijze en inrichting voor het regelen van de volumens van primaire en secondaire lucht die gemengd in een ruimte met geregelde toestand stromen.
FR2573283B1 (fr) Dispositif pour la diffusion dans l'atmosphere d'un produit parfume, desodorisant ou insecticide
FR2571251B1 (fr) Dispositif modulaire a distributeur pour l'application indolore d'aiguilles d'acupuncture steriles
DE3868979D1 (de) Vorrichtung zum verhindern des zurueckstroemens eines sprays in zahnaerztliche instrumente mit separaten luft- und wasserleitungen.
FR2664156B1 (fr) Dispositif pour le traitement et le conditionnement de semence animale destinee a l'insemination artificielle.
JPS5697670A (en) Stopping device of safety valve with blowwoff pipe
GB2142945B (en) Device for the dosage and injection of a small quantity of liquid into the splicing air of a pneumatic yarn splicing device
DE69002497D1 (de) Vorrichtung zur messung der lage einer beweglichen einrichtung laengs einer geraden sowie deren anwendung bei robotern.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time